ACCUPRIL

This brand name is authorized in Australia, Canada, United States, South Africa

Active ingredients

The drug ACCUPRIL contains one active pharmaceutical ingredient (API):

UNII 33067B3N2M - QUINAPRIL HYDROCHLORIDE

Quinapril is a potent angiotensin-converting enzyme (ACE) inhibitor. The mode of action of quinapril in humans and animals is to inhibit circulating and tissue ACE activity, thereby decreasing vasopressor activity and aldosterone secretion.

Read about Quinapril

Medication package inserts

Below package inserts are available for further reading:

ACCUPRIL Film-coated tablet

FDA, National Drug Code (US)

MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

C09AA06

Quinapril

C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain

Discover more medicines within C09AA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Pharmaceutical Benefits Scheme

Identifier(s): 1968N, 1969P, 1970Q

Health Products and Food Branch

Identifier(s): 01947664, 01947672, 01947680, 01947699

FDA, National Drug Code

Identifier(s): 0071-0527, 0071-0530, 0071-0532, 0071-0535

Health Products Regulatory Authority

Identifier(s): W/7.1.3/361, W/7.1.3/362, W/7.1.3/363, W/7.1.3/364

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.